Soliton, Inc.,, a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, will conduct a webcast to discuss its recent announcements regarding its significant discovery of acoustic subcision and its 510 clearance for its acoustic shockwave RAP device.
June 11, 2019
· 3 min read